Targeting mTORC2 inhibits colon cancer cell proliferation in vitro and tumor formation in vivo (Q33774353)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Targeting mTORC2 inhibits colon cancer cell proliferation in vitro and tumor formation in vivo	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20226010

retrieved

29 July 2017

title

Targeting mTORC2 inhibits colon cancer cell proliferation in vitro and tumor formation in vivo (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20226010

retrieved

29 July 2017

main subject

colon cancer

1 reference

based on heuristic

inferred from title

author

Olivier Dormond

series ordinal

5

object named as

Olivier Dormond

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20226010

retrieved

29 July 2017

author name string

Didier Roulin

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20226010

retrieved

29 July 2017

Yannick Cerantola

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20226010

retrieved

29 July 2017

Anne Dormond-Meuwly

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20226010

retrieved

29 July 2017

Nicolas Demartines

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20226010

retrieved

29 July 2017

publication date

12 March 2010

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20226010

retrieved

29 July 2017

published in

Molecular Cancer

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20226010

retrieved

29 July 2017

volume

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20226010

retrieved

29 July 2017

page(s)

57

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20226010

retrieved

29 July 2017

cites work

Biochemical, cellular, and in vivo activity of novel ATP-competitive and selective inhibitors of the mammalian target of rapamycin

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2850884

retrieved

28 July 2018

Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2850884

retrieved

28 July 2018

mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2850884

retrieved

28 July 2018

An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2850884

retrieved

28 July 2018

Inhibition of the mTORC1 pathway suppresses intestinal polyp formation and reduces mortality in ApcDelta716 mice

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2850884

retrieved

28 July 2018

mTORC2 activity is elevated in gliomas and promotes growth and cell motility via overexpression of rictor

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2850884

retrieved

28 July 2018

Defining the role of mTOR in cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2850884

retrieved

28 July 2018

Current development of mTOR inhibitors as anticancer agents

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2850884

retrieved

28 July 2018

Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2850884

retrieved

28 July 2018

TOR signaling in growth and metabolism

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2850884

retrieved

28 July 2018

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2850884

retrieved

28 July 2018

Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2850884

retrieved

28 July 2018

mTOR signaling pathway is a target for the treatment of colorectal cancer.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2850884

retrieved

30 October 2018

Akt2 overexpression plays a critical role in the establishment of colorectal cancer metastasis.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2850884

retrieved

30 October 2018

Upstream and downstream of mTOR

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2850884

retrieved

30 October 2018

Identifiers

DOI

10.1186/1476-4598-9-57

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20226010

retrieved

29 July 2017

Dimensions Publication ID

1052162150

1 reference

stated in

SciGraph

reference URL

https://scigraph.springernature.com/pub.10.1186/1476-4598-9-57

retrieved

9 September 2019

PMC publication ID

2850884

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20226010

retrieved

29 July 2017

PubMed publication ID

20226010

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20226010

retrieved

29 July 2017

ResearchGate publication ID

41941531

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33774353&oldid=2195772027"